Abstract
The actions of neuropeptide Y (NPY) on the circulation is currently the subject of much research that has been stimulated by findings of its co-storage and co-operation with noradrenaline in sympathetic nerve fibres. Lars Edvinsson and colleagues describe the evidence that NPY is involved in the regulation of the cardiovascular system as a neuromodulator/neurotransmitter. This may open novel avenues for the treatment of, for example, hypertension and vasospastic disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 231-235 |
| Number of pages | 5 |
| Journal | Trends in Pharmacological Sciences |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jan 1 1987 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
- Toxicology
Cite this
Effects of neuropeptide Y on the cardiovascular system. / Edvinsson, L.; Håkanson, R.; Wahlestedt, Claes R; Uddman, R.
In: Trends in Pharmacological Sciences, Vol. 8, No. 6, 01.01.1987, p. 231-235.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effects of neuropeptide Y on the cardiovascular system
AU - Edvinsson, L.
AU - Håkanson, R.
AU - Wahlestedt, Claes R
AU - Uddman, R.
PY - 1987/1/1
Y1 - 1987/1/1
N2 - The actions of neuropeptide Y (NPY) on the circulation is currently the subject of much research that has been stimulated by findings of its co-storage and co-operation with noradrenaline in sympathetic nerve fibres. Lars Edvinsson and colleagues describe the evidence that NPY is involved in the regulation of the cardiovascular system as a neuromodulator/neurotransmitter. This may open novel avenues for the treatment of, for example, hypertension and vasospastic disorders.
AB - The actions of neuropeptide Y (NPY) on the circulation is currently the subject of much research that has been stimulated by findings of its co-storage and co-operation with noradrenaline in sympathetic nerve fibres. Lars Edvinsson and colleagues describe the evidence that NPY is involved in the regulation of the cardiovascular system as a neuromodulator/neurotransmitter. This may open novel avenues for the treatment of, for example, hypertension and vasospastic disorders.
UR - http://www.scopus.com/inward/record.url?scp=0000523623&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0000523623&partnerID=8YFLogxK
U2 - 10.1016/0165-6147(87)90069-1
DO - 10.1016/0165-6147(87)90069-1
M3 - Article
VL - 8
SP - 231
EP - 235
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
SN - 0165-6147
IS - 6
ER -